PATENT CLAIM ANALYSIS

Application Number: 15897032
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-10
Patent Classification: ["514", "001000"]

Abstract:
Methods and compositions are provided for treating hyperproliferative disorders in patients with a PI3K inhibitor, GDC-0032 as a single agent or in combination with chemotherapeutic agents.

Claim (Index 26):
The method of  claim 25  wherein the mammal is administered the chemotherapeutic agent and subsequently administered GDC-0032.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 88.0
- Lexical Diversity: 1.12
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13912281', '12208227', '12400988', '13109670', '15438277']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8154589233258314
- 35 USC 102 Novelty (BERT): 0.7479813537559459
- Combined Prediction Score: 0.8087111663688428
- Mean Citation Score: 568.5882720000002
- Max Citation Score: 967.9128
- Similarity Product: 836.8758133363722

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test